Literature DB >> 12549909

Molecular recognition of the human coactivator CBP by the HIV-1 transcriptional activator Tat.

Andrew C Vendel1, Kevin J Lumb.   

Abstract

HIV-1 Tat is required for the expression of the viral genome. Tat binds to an RNA stem-loop and mediates the recruitment of human coactivators to facilitate HIV-1 transcription. The coactivator and acetyltransferase CREB binding protein (CBP), and the paralog p300, are recruited to the HIV-1 promoter by Tat. Here we identify the interacting domains of Tat and CBP. Circular dichroism and pulldown assays show that full-length Tat binds to the KIX domain of CBP, but not to the C/H1 or CR2 domains. Circular dichroism and NMR studies of Tat deletion mutants localize the KIX-binding domain of Tat to the N-terminal 24 residues of Tat. Transient cotransfections demonstrate that exogenous KIX behaves as a dominant negative to Tat-mediated transcription in human T-cells, suggesting that Tat and KIX interact in vivo. These findings indicate that Tat targets the KIX domain of CBP and provide insight into the molecular interactions involved in regulating HIV-1 gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12549909     DOI: 10.1021/bi0270034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking.

Authors:  Raffaella Pierleoni; Michele Menotta; Antonella Antonelli; Carla Sfara; Giordano Serafini; Sabrina Dominici; Maria Elena Laguardia; Annalisa Salis; Gianluca Damonte; Lucia Banci; Marco Porcu; Paolo Monini; Barbara Ensoli; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2010-08-20       Impact factor: 3.396

2.  Identification of a novel p300-specific-associating protein, PRS1 (phosphoribosylpyrophosphate synthetase subunit 1).

Authors:  Atsushi Kaida; Yasuo Ariumi; Keiko Baba; Masami Matsubae; Toshifumi Takao; Kunitada Shimotohno
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

Review 3.  Barriers for HIV Cure: The Latent Reservoir.

Authors:  Sergio Castro-Gonzalez; Marta Colomer-Lluch; Ruth Serra-Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-28       Impact factor: 2.205

Review 4.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

5.  Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.

Authors:  Chul Won Lee; Munehito Arai; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

6.  Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors.

Authors:  Sara J Buhrlage; Caleb A Bates; Steven P Rowe; Aaron R Minter; Brian B Brennan; Chinmay Y Majmudar; David E Wemmer; Hashim Al-Hashimi; Anna K Mapp
Journal:  ACS Chem Biol       Date:  2009-05-15       Impact factor: 5.100

7.  HIV protein sequence hotspots for crosstalk with host hub proteins.

Authors:  Mahdi Sarmady; William Dampier; Aydin Tozeren
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

8.  Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB.

Authors:  Elif Nihal Korkmaz; Ruth Nussinov; Türkan Haliloğlu
Journal:  PLoS Comput Biol       Date:  2012-03-15       Impact factor: 4.475

9.  Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.

Authors:  Emmanuel Agbottah; Longwen Deng; Luke O Dannenberg; Anne Pumfery; Fatah Kashanchi
Journal:  Retrovirology       Date:  2006-08-07       Impact factor: 4.602

10.  The landscape of human proteins interacting with viruses and other pathogens.

Authors:  Matthew D Dyer; T M Murali; Bruno W Sobral
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.